Skip to content

Repligen RGEN Other Working Capital

Other Working Capital at other companies

TEC
Bio-TechneTECH
$1M+7.1%
Agilent Technologies logo
Agilent TechnologiesA
$284M+51.9%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$8.52M+310%
Entegris logo
EntegrisENTG
-$4.7M-2,250%
STERIS logo
STERISSTE
$17.8M
Arrowhead Research logo
Arrowhead ResearchARWR
-$385K+78.2%

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's other working capital?
Repligen (RGEN) reported other working capital of $1.33M in Q1 2026.
How has Repligen's other working capital changed year-over-year?
Repligen's other working capital increased by 112.7% year-over-year, from -$10.48M to $1.33M.
What is the long-term trend for Repligen's other working capital?
Over 3 years (2021 to 2024), Repligen's other working capital has grown at a 57.4% compound annual growth rate (CAGR), from -$864K to -$3.37M.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.